University of Michigan   

University of Michigan Tumor Boards

Questions discussed in this category


DLCO 65% that is of unclear etiology but not due to disease and no cardiac or pulmonary functional limitations.

NGS without any actionable mutations and PD-L1 TPS 15%. Would you offer chemotherapy, radiation, or immunotherapy and, if so, in what order?

Most trials establishing CRT as standard of care for IIIB NSCLC excluded patients with separate ipsilateral lung nodules given that they were categori...

In clinical practice, consolidation chemotherapy is sometimes used, though this was not implemented in the PACIFIC trial.Antonia et al., PMID 28885881...


Papers discussed in this category


The New England journal of medicine, 2018-12-13

N Engl J Med, 2017 Nov 16

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-12-10

J Thorac Oncol, 2016 Jul

The Lancet. Respiratory medicine, 2017-11

JAMA oncology, 2017-05-01

Br J Cancer,

Haematologica, 2021 Jun 01

Lancet (London, England), 2019-01-19

N Engl J Med, 2020 Sep 19

The New England journal of medicine, 2023 Jun 04

Cancer cell, 2017-06-12

J Neurooncol, 2022 Jun 20